Alector (ALEC) Invested Capital (2025 - 2026)

Alector (ALEC) posted quarterly Invested Capital of $1.5 million for Q1 2026, up 304.37% quarter-over-quarter from $366000.0 in Q4 2025.

Alector (ALEC) Invested Capital (2025 - 2026) Analysis & Trends

Alector (ALEC) has reported Invested Capital for 2 consecutive years, with $1.5 million the latest figure, recorded in Q1 2026.

In Q1 2026, Invested Capital changed N/A year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $1.8 million (changed N/A YoY), while the FY2025 annual figure was $366000.0, changed N/A from the prior year.
Invested Capital advanced to $1.5 million in Q1 2026 per ALEC's latest filing, from $366000.0 in the prior quarter.
Across five years, Invested Capital topped out at $1.5 million in Q1 2026 and bottomed at $366000.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	190.90 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	2.57 Mn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	380.00 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	Alector	218.85 Mn	46.05 Mn	-	9.85 Mn

Download Data